Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.
2008
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus
2009
Use of Cidofovir for Cytomegalovirus Disease Refractory to Ganciclovir in Solid Organ Recipients
2016
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Cancer statistics, 2018
2018 Standout
Cytomegalovirus reactivation in critically ill immunocompetent hosts: A decade of progress and remaining challenges
2011
A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplant
2014
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
2007
Leishmaniasis
2018 Standout
Regulation of microRNA function in animals
2018 Standout
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
2004
Treatment of HCV infection with the novel NS3/4A protease inhibitors
2014
The “ABC” of Virus-Specific T Cell Immunity in Solid Organ Transplantation
2015
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis
2006
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
2011
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
2008
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
2007
Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults
2009
Pentoxifylline for Renoprotection in Diabetic Nephropathy: the PREDIAN study. Rationale and basal results
2010
Diagnostic test for etiologic agents of community-acquired pneumonia
2004
Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.
1998
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡
2010
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
2014
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
2007
The Role of Inflammatory Cytokines in Diabetic Nephropathy
2008
Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir
2003
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Viral Infection in the Renal Transplant Recipient
2005
Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago
2015
Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
2013
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts*
2008
Comparative Analysis of Assays for Detection of Cell-Mediated Immunity Toward Cytomegalovirus and M. tuberculosis in Samples From Deceased Organ Donors
2014
Hepatitis C
2015
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
The biological diagnosis of leishmaniasis in HIV-infected patients
2003
HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy
2000
Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation
2007
Is Sexual Contact a Major Mode of Hepatitis C Virus Transmission?
2010
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Brucellosis
2005 Standout
Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High-risk CMV D+/R- Transplant Recipients
2005
The Course of Posttransplant Hepatitis C Infection
2012
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection
2012
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
2006
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
2013
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Emerging Gram-Negative Infections in Burn Wounds
2011
Efficacy of Valganciclovir in the Treatment of Cytomegalovirus Disease in Kidney and Pancreas Transplant Recipients
2006
Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
2009
Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men
2012
Evolving challenges in hepatic fibrosis
2010
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis
2014
Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants
2015
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
2005
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
2011
Treatment of leishmaniasis in HIV-positive patients
2003
Simultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant Recipients
2012
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation
2014
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
2016
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
The pathogenesis ofLeishmania/HIV co-infection: cellular and immunological mechanisms
2003
Late-Onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?
2012
Reactivation of Multiple Viruses in Patients with Sepsis
2014
Concordant HIV Infection and Visceral Leishmaniasis in Ethiopia: The Influence of Antiretroviral Treatment and Other Factors on Outcome
2008
Impaired Direct Priming of CD8 T Cells by Donor-Derived Cytomegalovirus Following Kidney Transplantation
2013
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
Cytomegalovirus in Solid Organ Transplantation
2013
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients
1998
Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans
2015 StandoutNobel
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
1996
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Herpes Zoster
2013 Standout
CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients
2015
An International Survey of Cytomegalovirus Management Practices in Lung Transplantation
2010
Assessment of the Usefulness of Sputum Culture for Diagnosis of Community-Acquired Pneumonia Using the PORT Predictive Scoring System
2004
Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients
2008
Control of Neglected Tropical Diseases
2007 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Natural history of hepatitis C
2014
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Leishmaniasis
1999 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Silicosis
2012 Standout
Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients
2014
Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene
2017
Treatment of cytomegalovirus infection and disease pre‐ and post‐quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?
2015
Zygomycetes in Human Disease
2000 Standout
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma
2005
Treatment of Hepatitis C
2014
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
2013
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
2010
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Current scenario of drug development for leishmaniasis.
2006
Advances in leishmaniasis
2005 Standout
Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR
2004
Diabetic Kidney Disease
2017 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
2012
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial
2008
A new evolutionary scenario for the Mycobacterium tuberculosis complex
2002 Standout
Human Cytomegalovirus Resistance to Antiviral Drugs
2005
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Works of Antonio Rivero being referenced
Isolated renal mucormycosis in two AIDS patients
1994
Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy
2007
Failure of Cetirizine to Prevent Nevirapine-Associated Rash
2004
Visceral leishmaniasis in HIV-1 -infected individuals
1992
Clinical Epidemiology of Stenotrophomonas maltophilia Colonization and Infection
2002
Indirect effects of cytomegalovirus infection in solid organ transplant recipients
2008
Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients
2002
Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration
1999
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
2013
Selective Reactivation of Human Herpesvirus 6 Variant A Occurs in Critically Ill Immunocompetent Hosts
2002
CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantation
2010
Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus†
2009
Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy
2007
Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
2012
Ensayo clínico aleatorizado para evaluar tres pautas cortas de tratamiento de la infección latente tuberculosa en pacientes infectados por el VIH
2007
Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir
2001
Brucellosis in patients infected with the human immunodeficiency virus
1998
HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma
2013
Control of Epstein‐Barr Virus Load and Lymphoproliferative Disease by Maintenance of CD8+T Lymphocytes in the T Lymphocyte–Depleted Graft after Bone Marrow Transplantation
2004
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis
1997
Failure of a Short-Term Prednisone Regimen to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial: The GESIDA 09/99 Study
2001
Prediction of Response to Pegylated Interferon plus Ribavirin byIL28BGene Variation in Patients Coinfected with HIV and Hepatitis C Virus
2010
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV
2004
Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy
2011
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
2012
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
2013
Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease
2014
Natural History of Compensated Hepatitis C Virus–Related Cirrhosis in HIV‐Infected Patients
2009
Pretransplant Interferon-γ Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation
2013
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
2008
Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection
2003
Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients.
1997
Usefulness of Sputum Culture for Diagnosis of Bacterial Pneumonia in HIV-Infected Patients
2002
Use of High-Dose Ganciclovir for the Treatment of Cytomegalovirus Replication in Solid Organ Transplant Patients With Ganciclovir Resistance-Inducing Mutations
2013
50 BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN FOR THE TREATMENT OF HCV/HIV CO-INFECTED PATIENTS: END OF TREATMENT (WEEK 48) INTERIM RESULTS
2012
Use of Noninvasive Markers To Detect Leishmania Infection in Asymptomatic Human Immunodeficiency Virus-Infected Patients
2006
High Seroprevalence But Low Incidence of HCV Infection in a Cohort of Patients With Sexually Transmitted HIV in Andalusia, Spain
2009
Antiretroviral Therapy Based on Protease Inhibitors as a Protective Factor against Liver Fibrosis Progression in Patients with Chronic Hepatitis C
2006
Predictors of Severe Haematological Toxicity Secondary to Pegylated Interferon plus Ribavirin Treatment in HIV-HCV-Coinfected Patients
2007
Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High-Throughput Automated Systems
2001
Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir
2008
Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea
2003
FREQUENCY OF VISCERAL LEISHMANIASIS RELAPSES IN HUMAN IMMUNODEFICIENCY VIRUS–INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
2004
Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea
2003